MOUNTAIN VIEW, CA — (Marketwired) — 12/21/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it has completed a transaction for a Sensei X Robotic System at Maastricht University Medical Center in Maastricht, Netherlands. The commercial process was completed through a joint commercial effort with Medtronic International Trading SARL, a key partner with Maastricht University Medical Center, a prominent European therapeutic and training cente
MOUNTAIN VIEW, CA — (Marketwired) — 12/10/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it has accelerated the development of the latest addition to the Magellan Robotic System portfolio, the Magellan 3Fr Robotic Microcatheter. The development of this important product line expansion has surpassed key milestones and is moving toward the final stages of the development process.Hansen Medical continues to experience procedural growth wit
MOUNTAIN VIEW, CA — (Marketwired) — 12/07/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced further advancements in intravascular robotics combined with 3D imaging capabilities. This announcement coincides with activities taking place at this week–s Pumps and Pipes meeting in Houston, Texas, a collaborative association among thought-leaders in the medicine, aerospace, energy and academic industries.Hansen Medical is showcasing its latest
MOUNTAIN VIEW, CA — (Marketwired) — 11/16/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the 42nd Annual VEITHsymposium®, November 17 – 21 at the New York Hilton-Midtown in New York City. The Company will be conducting product demonstrations of the Magellan Robotic System and the related family of Magellan Robotic Catheters, including the Magellan 6Fr, 9Fr and 10Fr catheters. Hansen Med
MOUNTAIN VIEW, CA — (Marketwired) — 11/05/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today reported recent business highlights and financial results for the third quarter ended September 30, 2015.The Company today announces a broad cost reduction program, which when fully implemented, is expected to further reduce the break-even point of the company to approximately $40 million in annual revenue, improve cash flow and allow for further investment i
MOUNTAIN VIEW, CA — (Marketwired) — 10/08/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the shipment of the first Magellan Mobility Package for the Magellan Robotic System to the Miami Cardiac & Vascular Institute in Miami, FL, part of Baptist Health South Florida. MCVI is the first hospital in the U.S. to purchase Magellan Mobility, a package that consists of the Magellan Transport System in addition to the Magellan physician work
MOUNTAIN VIEW, CA — (Marketwired) — 10/05/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the shipment of the Magellan Robotic System to Holy Name Medical Center in Teaneck, New Jersey, the first hospital in the New York / New Jersey metropolitan area to purchase a system."We are excited for Holy Name Medical Center to be the first institution in the New York / New Jersey Metropolitan Area to offer robotic endovascular procedures wi
MOUNTAIN VIEW, CA — (Marketwired) — 10/01/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced that it has signed an exclusive agreement with AB Medica Sagl for distribution of the Magellan Robotic System in Switzerland. AB Medica, s.p.a. is the company–s exclusive distributor for Italy. As part of the agreement, Hansen Medical sold and shipped a Magellan system to AB Medica on September 30, 2015."We are pleased to expand our relationsh
MOUNTAIN VIEW, CA — (Marketwired) — 09/28/15 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the completion of the first robot-assisted Prostatic Artery Embolization (PAE) procedure in the United Kingdom with the Magellan Robotic System. Interventional Radiologist Dr. Mohammad Hamady performed the procedure at St. Mary–s Hospital, Imperial College in London. Dr. Hamady used the Magellan 6Fr Robotic Catheter for navigation in the peripheral
